← Back to Analyst Consensus 
VTRS Buy
Viatris Inc
Current Price —
Implied Upside —
Analysts 18
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 2 reiterations from 2 firms
Next Earnings
Nov 5, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 26, 2026 | liqdey cytvv | maintain | — | — | — |
| Oct 21, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 55% |
| Oct 5, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Sep 23, 2026 | Oppenheimer | initiate | — → Outperform | — | 52% |
| Sep 16, 2026 | Piper Sandler | maintain | Neutral → Neutral | — | 54% |
| Sep 9, 2026 | Leerink Partners | initiate | — → Outperform | — | 51% |
| Sep 8, 2026 | Argus Research | maintain | Buy → Buy | — | 54% |
| May 19, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| May 8, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 55% |
| May 8, 2026 | Truist Securities | maintain | Buy → Buy | — | 55% |
| Mar 24, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Jan 28, 2026 | Piper Sandler | maintain | Neutral → Neutral | $12 | 54% |
| Jan 16, 2026 | Argus Research | upgrade | Hold → Buy | $15 | 54% |
| Dec 9, 2025 | Barclays | initiate | — → Overweight | $15 | 53% |
| Oct 15, 2025 | Truist Securities | initiate | — → Buy | $15 | 55% |
| Jun 6, 2025 | Goldman Sachs | initiate | — → Neutral | $10 | 54% |
| Mar 7, 2025 | Jefferies | maintain | Buy → Buy | $13 | 52% |
| Mar 5, 2025 | Piper Sandler | reiterate | Neutral → Neutral | $10 | 54% |
| Feb 28, 2025 | Barclays | maintain | Underweight → Underweight | $9 | 53% |
| Feb 28, 2025 | B of A Securities | maintain | Underperform → Underperform | $10 | 53% |
| Dec 6, 2024 | Piper Sandler | reiterate | Neutral → Neutral | $14 | 54% |
| Nov 8, 2024 | Barclays | maintain | Underweight → Underweight | $12 | 53% |
| Mar 28, 2024 | Piper Sandler | reiterate | Neutral → Neutral | $13 | 54% |
| Nov 22, 2023 | Piper Sandler | maintain | Neutral → Neutral | $11 | 54% |
| Oct 23, 2023 | B of A Securities | downgrade | Neutral → Underperform | $9 | 53% |
| Jun 23, 2023 | Barclays | downgrade | Equal-Weight → Underweight | $11 | 53% |
| Apr 25, 2023 | Barclays | downgrade | Overweight → Equal-Weight | $11 | 53% |
| Apr 24, 2023 | Barclays | downgrade | Overweight → Equal-Weight | $11 | 53% |
| Feb 28, 2023 | Barclays | maintain | — → Overweight | $16 | 53% |
| Feb 17, 2023 | BMO Capital | downgrade | Outperform → Market Perform | $14 | 53% |
| Feb 1, 2023 | Barclays | maintain | — → Overweight | $15 | 53% |
| Jan 27, 2023 | Jefferies | upgrade | Hold → Buy | $15 | 52% |
| Nov 15, 2022 | JP Morgan | maintain | — → Neutral | $14 | 55% |
| Nov 10, 2022 | UBS | upgrade | Sell → Neutral | $12 | 54% |
| Nov 8, 2022 | Piper Sandler | upgrade | Underweight → Neutral | $10 | 54% |
| Oct 25, 2022 | Barclays | maintain | — → Overweight | $16 | 53% |
| Oct 21, 2022 | Jefferies | initiate | — → Hold | $11 | 52% |
| Aug 9, 2022 | BMO Capital | maintain | — → Outperform | $16 | 53% |
| Jun 14, 2022 | UBS | initiate | — → Sell | $9 | 54% |
| May 12, 2022 | Goldman Sachs | maintain | — → Neutral | $11 | 54% |
| May 10, 2022 | Piper Sandler | downgrade | Neutral → Underweight | $10 | 54% |
| Mar 16, 2022 | Piper Sandler | maintain | — → Neutral | $10 | 54% |
| Mar 10, 2022 | Citigroup | maintain | — → Neutral | $11 | 54% |
| Mar 1, 2022 | B of A Securities | downgrade | Buy → Neutral | $13 | 53% |
| Mar 1, 2022 | Raymond James | downgrade | Outperform → Market Perform | $0 | 54% |
| Jun 15, 2021 | Citigroup | initiate | — → Neutral | $16 | 54% |
| Mar 10, 2021 | Morgan Stanley | maintain | — → Equal-Weight | $16 | 54% |
| Mar 8, 2021 | Goldman Sachs | downgrade | Buy → Neutral | $15 | 54% |
| Mar 2, 2021 | JP Morgan | downgrade | Overweight → Neutral | $18 | 55% |
| Feb 23, 2021 | Raymond James | maintain | — → Outperform | $19 | 54% |
Price Target Trend
Jul 20, 2026 Oct 26, 2026
EPS Estimates
0y —
0q —
+1y —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days